Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - monitor: Difference between revisions

From GxPlex

Jump to: navigation, search
m 1 revision imported
imported>GxPlexBot
Import from GxPlex Excel
Line 4: Line 4:
|RefDocPart=Glossary - monitor
|RefDocPart=Glossary - monitor
|RefLanguage=EN
|RefLanguage=EN
|RefTagsEN=
|RefTags=TAG-00020-Cli-nit ++ TAG-00244-Def-ini ++ TAG-00137-Mon-che ++ TAG-00017-Spo-die ++ TAG-00148-Con-rsc
|RefTagsOriginal=
|RefModule=4
|RefTagsFR=
|RefUnit=4.3.1
}}
}}


Line 14: Line 14:
|-
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 4 — Unit 4.3.1
|-
|-
! Scope
! Scope
Line 30: Line 33:
|  
|  
|-
|-
! Tags (EN)
! Tags
|  
| [[Glossary:TAG-00020-Cli-nit|CRA / Monitor]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00137-Mon-che|Monitoring]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00148-Con-rsc|CRO]]
|-
! Tags (original language)
|  
|-
! Tags (FR)
|  
|-
|-
! Comment
! Comment

Revision as of 17:29, 15 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 4 — Unit 4.3.1
Scope HM
Document part Glossary - monitor
Language EN
Original entry by Florian Adragna
Contributors
Tags CRA / Monitor, Definition, Monitoring, Sponsor, CRO
Comment Definition of monitor

Content

monitor A person appointed by, and responsible to, the sponsor or Contract Research Organization (CRO) for the monitoring and reporting of progress of the trial and for verification of data.